Video

Dr. Alter Discusses Research at JTCC

Author(s):

Robert S. Alter, MD

Dr. Robert Alter on Current Research at John Theurer Cancer Center

Robert S. Alter, M.D. Co-chief, Urologic Oncology, John Theurer Cancer Center, discusses research taking place at the John Theurer Cancer Center, in the spring of 2011.

Related Videos
Minoo Battiwalla, MD, MS
Cynthia X. Ma, MD, PhD
Jyoti Patel, MD
Leo I. Gordon, MD
Bertram Yuh, MD, MISM, MSHCPM
Alexander Drilon, MD
David Rimm, MD, PhD
Laahn Ho Foster, MD
David C. Fisher, MD
Michel Ducreux, MD, PhD, head, Gastrointestinal Oncology Unit, head, Gastrointestinal Oncology Tumor Board, Gustave Roussy; professor, oncology, Paris-Saclay University
Related Content
Yair Lotan, MD, professor, urology, chief, Urologic Oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Medical Center
October 24th 2024

Investigative Targeted Agents Are Set to Expand the BCG-Unresponsive NMIBC Treatment Paradigm

Oncology Unplugged
August 7th 2024

Park and Grivas Expand on Treatment Updates in Bladder Cancer

FDA
October 21st 2024

FDA Approves IDH1/2+ Companion Diagnostic for Vorasidenib in Grade 2 Astrocytoma or Oligodendroglioma

Oncology Unplugged
July 24th 2024

Park and Sonpavde on Sacituzumab Govitecan Plus Enfortumab Vedotin in Metastatic Urothelial Cancer

Alan Tan, MD
October 18th 2024

Long-Term IO-IO Data Contest the Role of Frontline TKIs in Advanced RCC

FDA
October 18th 2024

FDA Approves Zolbetuximab Plus Chemo for CLDN18.2+ Gastric or GEJ Adenocarcinoma